Antti-Heikki Tapio, a member of Uniogen’s R&D team, shares his inspiring journey in biotechnology and the background of the GenomEra GBS Assay Kit. Antti-Heikki started studying at Turku University of Applied Sciences in 2002 and continued his studies at… Read More
Uniogen has been selected to participate in a climate program led by The Finland Chamber of Commerce and supported by LähiTapiola, representing a significant advancement in environmental responsibility for small and medium-sized businesses. This participation reflects a growing commitment to engage in climate action. The program equips participating companies with… Read More
Uniogen’s cancer diagnostic platform is based on research conducted and published at the University of Turku. Studies show that the concept of glycosylation-specific immunoassays is clearly superior to currently used blood-based markers in cancer diagnosis and monitoring. See the… Read More
Uniogen has achieved a remarkable milestone by receiving the esteemed Seal of Excellence from the European Innovation Council (EIC). This recognition comes as a testament to Uniogen’s pioneering work in the field of cancer diagnostics, solidifying its position as an innovator and leader in healthcare technology. The Seal of… Read More
Uniogen showcased innovation and collaboration at MEDICA 2023 Uniogen had a significant presence at MEDICA 2023, one of the largest medical and healthcare technology trade fairs globally. “Medica is an important annual venue for Uniogen” said Tapani Elovirta, Commercial Director of Uniogen. “This year, after the pandemic, the fair was… Read More
A big thank you to all of you for cooperating with us this year. You are very important to us, and we are glad you are with us. Enjoy the Holiday Season! Uniogen team will be taking a break… Read More
Detecting ovarian cancer early has always been challenging, but Uniogen’s test under development, is changing that. Dive in to see how this Finnish innovation is set to make a big difference, offering hope and better solutions in cancer care. Traditionally, early diagnosis of ovarian cancer has been challenging. However, Uniogen… Read More
Recognized as one of the world’s largest B2B trade fairs for the medical sector, MEDICA attracts more than 81,000 visitors globally. The event features over 4,500 exhibitors from 66 countries, showcasing pioneering products and services spanning medical imaging, health IT, laboratory technology, mobile health, and much more. … Read More
Imagine a night sky where stars shine brighter than ever before, free from the interference of urban light pollution. Upcon nanoparticles emit their unique glow through a special luminescence phenomenon, making even the faintest of glows distinctly visible. This is how Dr. Terhi Riuttamäki, our R&D scientist,… Read More
Uniogen Oy and a Swedish company Lumito AB have signed a cooperation agreement for the production of Lumito’s immunohistochemical reagent kit, SCIZYS Erbium Kit. The reagent kit is part of Lumito’s product offering and is based on upconverted nanoparticles. Since June 2022, Lumito has had a Letter of Intent… Read More
